LIKARDA
LIVE

Serial Number

98559551

Owner

Likarda, LLC

Attorney

C. Blair Barbieri

First Use Date

Dec 13, 2022

Filing Date

May 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LIKARDA Trademark

Serial Number: 98559551 • Registration: 7783457

LIKARDA is a trademark filed by Likarda, LLC on May 20, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently registered and active.

Owner Contact Info

Likarda, LLC (14 trademarks)

2002 W. 39th Ave.
Kansas City, KS 66103

Entity Type: 16

Trademark Details

Filing Date

May 20, 2024

Registration Date

May 6, 2025

First Use Anywhere

December 13, 2022

First Use in Commerce

December 13, 2022

Published for Opposition

March 18, 2025

Goods & Services

Custom manufacturing services for others in the fields of pharmaceuticals, cosmetics, and veterinary preparations, featuring encapsulation and injectable hydrogel drug delivery systems for pharmaceutical drugs and biologics

Injectable gels in the nature of a hydrogel microbead solution for medical purposes used for viscosupplementation for the treatment of osteoarthritis; Injectable gels in the nature of a hydrogel microbead solution for medical purposes used as a drug delivery agent that facilitates the delivery of a wide range of pharmaceuticals; Injectable gels in the nature of a hydrogel microbead solution with stem cells, adult differentiated cells, biologics, proteins, peptides, antibodies, extracellular vesicles, piezo-emitting biological products, cell clusters, organoids, cell-based tissues, and small molecule biological products for medical purposes used for viscosupplementation for the treatment of osteoarthritis; Injectable gels in the nature of a hydrogel microbead solution with stem cells, adult differentiated cells, biologics, proteins, peptides, antibodies, extracellular vesicles, piezo-emitting biological products, cell clusters, organoids, cell-based tissues, and small molecule biological products for medical purposes used as a drug delivery agent that facilitates the delivery of a wide range of pharmaceuticals; Injectable gels in the nature of bulk hydrogel solutions for medical purposes used for viscosupplementation for the treatment of osteoarthritis; Injectable gels in the nature of bulk hydrogel solutions for medical purposes used as a drug delivery agent that facilitate the delivery of a wide range of pharmaceuticals; Medical preparations, namely, cellbased tissues and cell clusters for human health and veterinary organ transplantation

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 14, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 14, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 14, 2025 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 20, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 22, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 6, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 6, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 6, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2024 NWOS
NEW APPLICATION ENTERED
May 20, 2024 NWAP